Switching from dupilumab to tralokinumab in patients with atopic dermatitis due to inefficacy or side effects.

Fecha de publicación: 01/01/2024 Fecha Ahead of Print: 28/11/2023

Autores de IIS La Fe

Abstract no disponible

Lasheras-Pérez MA:: Department of Dermatology, La Fe University and Polytechnic Hospital, Valencia, Spain
Palacios-Diaz RD:: Department of Dermatology, La Fe University and Polytechnic Hospital, Valencia, Spain
Pozuelo-Ruiz M:: Department of Dermatology, La Fe University and Polytechnic Hospital, Valencia, Spain
Torres-Navarro I:: Department of Dermatology, La Fe University and Polytechnic Hospital, Valencia, Spain
Botella-Estrada R:: Department of Dermatology, La Fe University and Polytechnic Hospital, Valencia, Spain

Department of Dermatology, University of Valencia, Valencia, Spain
Rodriguez-Serna M:: Department of Dermatology, La Fe University and Polytechnic Hospital, Valencia, Spain